Capturing Autoinhibited PDK1 Reveals the Linker's Regulatory Role, Informing Innovative Inhibitor Design.

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Signaling

Background:

• PDK1 (3-phosphoinositide-dependent protein kinase-1) is essential for PI3K/AKT/mTOR and Ras/MAPK cancer signaling pathways.
• PDK1 phosphorylates AKT in a PIP3-dependent manner and other kinases (S6K, SGK, RSK) independently of PIP3.
• The autoinhibited monomeric state of PDK1 and its PIP3-independent phosphorylation mechanisms remained unclear.

Purpose of the Study:

• To elucidate the activation mechanism of PDK1 using computational modeling and simulations.
• To understand the structural basis of PDK1's autoinhibition and its regulation by the linker region.
• To identify novel strategies for developing PDK1-targeted cancer inhibitors.

Main Methods:

• All-atom molecular dynamics simulations guided by experimental data.
• Construction of computational models of PDK1 conformations.
• Analysis of protein-protein interactions and salt bridge formation.

Main Results:

• The autoinhibited PDK1 conformation involves linker binding to the PIF-binding pocket, forming a Glu130-Lys111 salt bridge.
• Substrate interaction with the PIF-binding pocket releases autoinhibition, even without PIP3.
• Linker phosphorylation further destabilizes the kinase-PH domain association, promoting an active state.

Conclusions:

• PDK1's autoinhibited state readily transitions to an active state, enabling substrate phosphorylation.
• The linker region plays a critical regulatory role in PDK1 activation.
• Two novel linker-based inhibitor strategies were proposed: locking autoinhibition or mimicking linker interactions.